Interesting article in BioProcess Online, written by Carla Reed (Founder/CEO, NewCreedLLC) from February 25, 2019: “Recalibrating The Supply Chain For Allogeneic Cell Therapies”. You can read the whole article at BioProcess Online HERE.
At Savsu, we working with clients preparing allogenic products for trials and commercialization and, we agree, the supply chain challenges are unique. Our hardware sizing flexibility, partnership with the leading specialty couriers, evo DV access to regional jets, and powerful communications module in evo.is help to build a robust, efficient, flexible supply chain. Contact us if you would like to explore this topic.
Note: If you missed her previous article on designing a successful supply chain for autologous therapies, “Establishing A Critical Supply Chain For Autologous Cell And Gene Therapies” (November 15, 2018), you can read it HERE. “
And…you can visit Carla’s NewCreed LLC website HERE.